OTCMKTS:CVALF Covalon Technologies (CVALF) Stock Price, News & Analysis $1.92 +0.02 (+1.05%) As of 07/7/2025 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesShort InterestBuy This Stock About Covalon Technologies Stock (OTCMKTS:CVALF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Covalon Technologies alerts:Sign Up Key Stats Today's Range$1.91▼$1.9250-Day Range$1.63▼$2.0552-Week Range$1.46▼$3.08Volume2,150 shsAverage Volume3,565 shsMarket Capitalization$52.65 millionP/E Ratio21.34Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian life sciences company specializing in the development and commercialization of infection prevention and wound care technologies. The company’s core competencies lie in advanced antimicrobial coatings, biocompatible wound dressings and medical device technologies designed to reduce the risk of infection in surgical and acute care settings. Covalon’s product pipeline includes implantable antimicrobial coatings for orthopaedic and reconstructive devices, transparent wound care dressings that deliver targeted antimicrobial agents, and advanced catheter coatings engineered to combat central line–associated bloodstream infections. Founded in 2001 and headquartered in Vancouver, British Columbia, Covalon has expanded its global footprint with commercial operations across North America, Europe and select markets in Asia. The company leverages a network of distributors and strategic partnerships to bring its proprietary technologies into hospitals, clinics and specialty care centers. Its manufacturing facilities conform to ISO 13485 standards, and its regulatory clearances span Health Canada, the U.S. Food and Drug Administration and the European CE marking process. Under the guidance of an executive team with extensive expertise in biomedical engineering, regulatory affairs and medical device commercialization, Covalon continues to advance its research programs and pursue opportunities in emerging wound care markets. The leadership’s focus on strategic collaborations and intellectual property development positions the company to address unmet clinical needs and to drive long-term growth in infection prevention and wound management sectors.AI Generated. May Contain Errors. Read More Receive CVALF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address CVALF Stock News HeadlinesCovalon Technologies Ltd. (CVALF) Q2 2025 Earnings Call TranscriptMay 28, 2025 | seekingalpha.comCovalon Reports Fifth Consecutive Quarter of Positive EarningsMay 28, 2025 | financialpost.comFTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything. | Paradigm Press (Ad)Covalon Reports Fifth Consecutive Quarter of Positive EarningsMay 28, 2025 | financialpost.comFCovalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line GuardMay 27, 2025 | finance.yahoo.comCovalon Retains Financial and Strategic Advisor to Advise on Shareholder Value-Enhancing OpportunitiesMay 20, 2025 | financialpost.comFCovalon Retains Financial and Strategic Advisor to Advise on Shareholder Value-Enhancing OpportunitiesMay 20, 2025 | financialpost.comFCovalon Technologies Promotes Kim Crooks to COO and Board MemberMay 15, 2025 | tipranks.comSee More Headlines CVALF Stock Analysis - Frequently Asked Questions How have CVALF shares performed this year? Covalon Technologies' stock was trading at $2.24 at the beginning of 2025. Since then, CVALF shares have decreased by 14.3% and is now trading at $1.92. How were Covalon Technologies' earnings last quarter? Covalon Technologies Ltd. (OTCMKTS:CVALF) released its earnings results on Wednesday, May, 28th. The company reported $0.01 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.01. The company earned $5.27 million during the quarter, compared to the consensus estimate of $7.67 million. Covalon Technologies had a net margin of 10.95% and a trailing twelve-month return on equity of 13.40%. How do I buy shares of Covalon Technologies? Shares of CVALF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/28/2025Today7/08/2025Next Earnings (Estimated)8/19/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryN/A Current SymbolOTCMKTS:CVALF CIKN/A Webwww.covalon.com Phone(905) 568-8400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)$0.09 Trailing P/E Ratio21.34 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.96 million Net Margins10.95% Pretax Margin10.93% Return on Equity13.40% Return on Assets11.59% Debt Debt-to-Equity RatioN/A Current Ratio8.39 Quick Ratio6.09 Sales & Book Value Annual Sales$22.91 million Price / Sales2.30 Cash Flow$0.10 per share Price / Cash Flow19.37 Book Value$0.74 per share Price / Book2.59Miscellaneous Outstanding Shares27,420,000Free FloatN/AMarket Cap$52.65 million OptionableNot Optionable Beta0.54 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (OTCMKTS:CVALF) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Covalon Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Covalon Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.